Showing results (151-160 of 548) with videos related to
Sort By:
Pageof 55
Pharmaceutics|March 19, 2014
Hollow pollen shells to enhance drug deliveryAlberto Diego-Taboada, Stephen T Beckett, Stephen L Atkin, et al.American Journal of Medical Genetics|February 27, 2001
Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCPD F Barker, J C Denison, C L Atkin, et al.Head & Neck|September 18, 2010
Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidismJames W Moor, Steven Roberts, Steven L Atkin, et al.International Journal of Molecular Sciences|October 27, 2022
Components of the Complement Cascade Differ in Polycystic Ovary SyndromeAlexandra E Butler, Abu Saleh Md Moin, Thozhukat Sathyapalan, et al.Annals of Clinical Biochemistry|August 10, 2004
Hypopituitarism presenting as a mixed hyperlipidaemiaEric S Kilpatrick, Jane E Patmore, Christopher Rowland-Hill, et al.International Journal of Molecular Sciences|January 11, 2025
Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Their Ratios in Women with Polycystic Ovary Syndrome and Healthy ControlsAlexandra E Butler, Manjula Nandakumar, Thozhukat Sathyapalan, et al.International Journal of Molecular Sciences|June 27, 2024
A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin DManjula Nandakumar, Priya Das, Thozhukat Sathyapalan, et al.Genome|October 13, 2006
Determination of mRNA half-lives in Candida albicans using thiolutin as a transcription inhibitorBessie W Kebaara, Lindsey E Nielsen, Kenneth W Nickerson, et al.Annals of Clinical Biochemistry|May 18, 2006
Dehydroepiandrosterone sulphate interferes with the Abbott Architect direct immunoassay for testosteroneM H Warner, J W Kane, S L Atkin, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 1994
Benign intracranial hypertension associated with the withdrawal of a non-ergot dopamine agonistS L Atkin, E A Masson, L D Blumhardt, et al.Pageof 55